Atossa Therapeutics, Inc. (ATOS)
NASDAQ: ATOS · Real-Time Price · USD
0.858
+0.006 (0.68%)
Jan 30, 2025, 12:33 PM EST - Market open
Atossa Therapeutics Market Cap
Atossa Therapeutics has a market cap or net worth of $107.18 million as of January 30, 2025. Its market cap has decreased by -5.98% in one year.
Market Cap
107.18M
Enterprise Value
32.49M
1-Year Change
-5.98%
Ranking
Category
Stock Price
$0.85
Market Cap Chart
Since November 8, 2012, Atossa Therapeutics's market cap has increased from $62.00M to $107.18M, an increase of 72.88%. That is a compound annual growth rate of 4.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 29, 2025 | 107.30M | -9.68% |
| Dec 31, 2024 | 118.80M | 7.71% |
| Dec 29, 2023 | 110.30M | 64.87% |
| Dec 30, 2022 | 66.90M | -66.98% |
| Dec 31, 2021 | 202.60M | 197.94% |
| Dec 31, 2020 | 68.00M | 375.52% |
| Dec 31, 2019 | 14.30M | 146.55% |
| Dec 31, 2018 | 5.80M | -17.14% |
| Dec 29, 2017 | 7.00M | 32.08% |
| Dec 30, 2016 | 5.30M | -45.36% |
| Dec 31, 2015 | 9.70M | -72.36% |
| Dec 31, 2014 | 35.10M | -16.03% |
| Dec 31, 2013 | 41.80M | -17.06% |
| Dec 31, 2012 | 50.40M | -18.71% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 724.84B |
| UnitedHealth Group | 499.24B |
| Novo Nordisk | 378.98B |
| Johnson & Johnson | 362.06B |
| AbbVie | 308.91B |
| Merck & Co. | 246.51B |
| Thermo Fisher Scientific | 223.49B |
| Abbott Laboratories | 220.95B |